• OPEN AN ACCOUNT
Indian Indices
Sensex
73,895.74 315.20
( 0.43%)
Global Indices
Nasdaq
51,839.66 468.68
(0.91%)
Dow Jones
7,763.25 38.12
(0.49%)
Hang Seng
66,308.10 794.11
(1.21%)
Nikkei 225
10,694.57 14.58
(0.14%)
Forex
USD-INR
95.89 0.16
(0.16%)
EUR-INR
109.08 -0.12
(-0.11%)
GBP-INR
126.82 -0.30
(-0.24%)
JPY-INR
0.60 0.00
(-0.20%)

EQUITY - MARKET SCREENER

Biocon Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
532523
INE376G01013
167.9878498
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
BIOCON
205.95
62091.35
EPS(TTM)
Face Value()
Div & Yield %
1.85
5
0.13
 

Privi Speciality Chemicals consolidated net profit rises 40.86% in the March 2026 quarter
May 11,2026
Net profit of Privi Speciality Chemicals rose 40.86% to Rs 93.70 crore in the quarter ended March 2026 as against Rs 66.52 crore during the previous quarter ended March 2025. Sales rose 17.60% to Rs 721.52 crore in the quarter ended March 2026 as against Rs 613.55 crore during the previous quarter ended March 2025.

For the full year,net profit rose 75.16% to Rs 327.54 crore in the year ended March 2026 as against Rs 187.00 crore during the previous year ended March 2025. Sales rose 22.01% to Rs 2563.69 crore in the year ended March 2026 as against Rs 2101.19 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales721.52613.55 18 2563.692101.19 22
OPM %24.9821.61 -25.2121.58 -
PBDT166.17124.85 33 583.50386.28 51
PBT129.6889.93 44 439.70254.52 73
NP93.7066.52 41 327.54187.00 75